SCM
ALBO

Sio Capital Management’s Albireo Pharma Inc ALBO Stock Holding History

Sio Capital Management’s Portfolio ALBO Stock Details ALBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-58,556
Closed -$1.16M – 64
2022
Q2 		$1.16M Sell
58,556
-85,990
-59% -$2.27M 0.44% 40
2022
Q1 		$4.31M Sell
144,546
-69,367
-32% -$2.03M 1.43% 20
2021
Q4 		$4.98M Buy
213,913
+420
+0.2% +$11.2K 1.5% 19
2021
Q3 		$6.66M Sell
213,493
-52,123
-20% -$1.61M 2.12% 16
2021
Q2 		$9.34M Sell
265,616
-2,730
-1% -$88.8K 2.32% 11
2021
Q1 		$9.46M Sell
268,346
-85,864
-24% -$3.17M 1.92% 13
2020
Q4 		$13.3M Sell
354,210
-124,414
-26% -$4.52M 2.72% 6
2020
Q3 		$16M Buy
+478,624
New +$13.9M 3.16% 7
2015
Q3 		– Sell
-5,351
Closed -$165K – 47
2015
Q2 		$165K Buy
+5,351
New +$180K 0.08% 39

Other funds holding ALBO

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return

Sio Capital Management's ALBO Position: Q3 2022 in Review

Sio Capital Management sold out of Albireo Pharma Inc (ALBO) in Q3 2022, closing a stake of 58,556 shares — an estimated $1.16M sold.

Sio Capital Management first reported a position in ALBO in Q2 2015 and held it in 9 quarters. The position peaked at $16M in Q3 2020. 108 funds tracked by Wall St. Rank hold ALBO as of Q3 2022.

  • Sio Capital Management reported no remaining Albireo Pharma Inc position as of Q3 2022 after selling out during the quarter.
  • Sio Capital Management sold 58,556 Albireo Pharma Inc shares in Q3 2022, an estimated $1.16M.
  • Sio Capital Management first reported a position in Albireo Pharma Inc in Q2 2015 and held it in 9 quarters.
  • Sio Capital Management's Albireo Pharma Inc position peaked at $16M in Q3 2020.
  • 108 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q3 2022.

Based on Sio Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.